Stock 5LB BIOVAXYS TECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News BioVaxys Technology Corp. Deutsche Boerse AG

Equities

5LB

CA09076M1014

Delayed Deutsche Boerse AG
Other stock markets
 02:01:53 2024-05-17 am EDT 		5-day change 1st Jan Change
0.0365 EUR -.--% Intraday chart for BioVaxys Technology Corp. -.--% +107.39%
May. 02 Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024 CI
Apr. 30 BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
AQ
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)
NE
Canadian Investment Regulatory Organization Trading Halt - BIOV
AQ
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
AQ
BioVaxys Technology Corp. Closes First Tranche of Private Placement
AQ
Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024
CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
AQ
BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer
CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry
CI
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage
CI
BioVaxys Technology Plans Private Placement; Down 5.9%
MT
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT
AQ
BioVaxys Technology Corp. announced that it expects to receive CAD 1 million in funding
CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
MT
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOV Stock
  4. 5LB Stock
  5. News BioVaxys Technology Corp.